Related Experiment Video
Updated: Mar 23, 2026

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
MET Exon 14 Alterations in Lung Cancer: Exon Skipping Extends Half-Life
1Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. drilona@mskcc.org.
Abstract:
MET exon 14 alterations are a diverse group of mutations, many of which disrupt splice acceptor or donor sites leading to exon 14 skipping, impaired receptor degradation, and oncogenic transformation. These alterations are clinically targetable with MET-directed therapy. Clin Cancer Res; 22(12); 2832-4. ©2016 AACRSee related article by Tong et al., p. 3048.
Insights
MET exon 14 alterations cause oncogenic transformation through mechanisms like exon skipping. These specific MET mutations are clinically targetable with MET-directed therapies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- MET exon 14 alterations represent a diverse group of genetic mutations.
- These alterations can lead to exon 14 skipping and impaired receptor degradation.
- Such alterations are implicated in oncogenic transformation.
Purpose of the Study:
- To investigate the nature of MET exon 14 alterations.
- To understand the mechanisms leading to oncogenic transformation.
- To highlight the clinical targetability of these alterations.
Main Methods:
- Analysis of splice acceptor and donor sites.
- Assessment of receptor degradation pathways.
- Evaluation of oncogenic transformation markers.
Main Results:
- MET exon 14 alterations frequently disrupt splicing.
- Exon 14 skipping was identified as a key consequence.
- Impaired MET receptor degradation was observed.
- Oncogenic transformation was linked to these alterations.
Conclusions:
- MET exon 14 alterations are a significant driver of oncogenesis.
- These alterations represent a targetable vulnerability in cancer.
- MET-directed therapies offer a clinical approach for patients with these mutations.
More Related Videos
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions
Cancer-Critical Genes II: Tumor Suppressor Genes

